The pancreatohepatorenal cAMP-adenosine mechanism

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 2, 2007, Pages 799-809

  Jackson, Edwin K ^a   Mi, Zaichuan ^a   Zacharia, Lefteris C ^a   Tofovic, Stevan P ^a   Dubey, Raghvendra K ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; ADENOSINE; ADENYLATE CYCLASE; CYCLIC AMP; ECTO 5' NUCLEOTIDASE; ECTOPHOSPHODIESTERASE; GLUCAGON; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE; PROBENECID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE TOLERANCE TEST; MALE; METABOLIC SYNDROME X; NONHUMAN; PANCREAS SECRETION; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; RAT; TARGET ORGAN;

ADENOSINE; ADENOSINE MONOPHOSPHATE; ANIMALS; CYCLIC AMP; GLUCAGON; GLUCOSE; INOSINE; KIDNEY; LIVER; MALE; MICRODIALYSIS; PANCREAS; PROBENECID; RATS;

EID: 34247216174     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.119164     Document Type: Article

References (41)

1. Albert B, Bray D, Lewis J, Raff M, Roberts K, and Watson JD (1989) Molecular Biology of the Cell, pp 825-826, Garland Publishing Inc., New York.
2. Bankir L, Ahloulay M, Devreotes PN, and Parent CA (2002) Extracellular cAMP inhibits proximal reabsorption: are plasma membrane cAMP receptors involved? Am J Physiol 282:F376-F392.
3. Bankir L, Martin H, Dechaux M, and Ahloulay M (1997) Plasma cAMP: a hepatorenal link influencing proximal reabsorption and renal hemodynamics? Kidney Int Suppl 59:S50-S56.
4. Beavo JA and Reifsnyder DH (1990) Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11:150-155.
5. Broadus AE, Kaminsky NI, Northcutt RC, Hardman JG, Sutherland EW, and Liddle GW (1970) Effects of glucagon on adenosine 3′,5′- monophosphate and guanosine 3′,5′-monophosphate in human plasma and urine. J Clin Investig 49:2237-2245.
6. Cramer H and Lindl T (1974) Release of cyclic AMP from rat superior cervical ganglia after stimulation of synthesis in vitro. Nature (Lond) 249:380-382.
7. Dubey RK, Gillespie DG, and Jackson EK (1998) Cyclic AMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells. Hypertension 31:296-302.
8. Dubey RK, Gillespie DG, Mi Z, and Jackson EK (1997) Cyclic AMP-adenosine pathway inhibits glomerular mesangial cell growth (Abstract). Hypertension 30:506.
9. Dubey RK, Gillespie DG, Mi Z, and Jackson EK (2000) Cardiac fibroblasts express the cAMP-adenosine pathway. Hypertension 36:337-342.
10. Dubey RK, Gillespie DG, Mi Z, and Jackson EK (2001) Endogenous cyclic AMPadenosine pathway regulates cardiac fibroblast growth. Hypertension 37:1095-1100.
11. Dubey RK, Mi Z, Gillespie DG, and Jackson EK (1996) Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth. Hypertension 2:765-771.
12. Finnegan RB and Carey GB (1998) Characterization of cyclic AMP efflux from swine adipocytes in vitro. Obesity Res 6:292-298.
13. Geddes DM, Blackburn JP, Bailey JS, and Muller FJ (1979) Effects of pulmonary circulation on blood levels of insulin and glucagon in ambulant dogs. J Appl Physiol 46:593-598.
14. Gogel E, Halloran BP, and Strewler GJ (1983) Probenecid inhibits the secretion of nephrogenous adenosine 3′,5′-monophosphate in normal man. J Clin Endocrinol Metab 57:689-693.
15. Houslay MD (1986) Insulin, glucagon and the receptor-mediated control of cyclic AMP concentrations in liver. Twenty-second Colworth medal lecture. Biochem Soc Trans 14:183-193.
16. Huang DY, Vallon V, Zimmermann H, Koszalka P, Schrader J, and Osswald H (2006) Ecto-5′-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo. Am J Physiol 291:F282-F288.
17. Iannello S, Campione R, and Belfiore F (1998) Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension. Mol Gen Metab 63:214-223.
18. Jackson EK and Dubey RK (2004) The extracellular cyclic AMP-adenosine pathway in renal physiology. Annu Rev Physiol 66:571-599.
19. Jackson EK and Mi Z (2000) Preglomerular microcirculation expresses the cAMP-adenosine pathway. J Pharmacol Exp Ther 295:23-28.
20. Jackson EK, Mi Z, Gillespie DG, and Dubey RK (1997) Metabolism of cAMP to adenosine in the renal vasculature. J Pharmacol Exp Ther 283:177-182.
21. Jackson EK, Mi Z, Koehler MT, Carcillo JA Jr, and Herzer WA (1996) Injured erythrocytes release adenosine deaminase into the circulation. J Pharmacol Exp Ther 279:1250-1260.
22. Jackson EK, Mi Z, Zhu C, and Dubey RK (2003) Adenosine biosynthesis in the collecting duct. J Pharmacol Exp Ther 307:888-896.
23. Jackson EK, Zacharia LC, Zhang M, Gillespie DG, Zhu C, and Dubey RK (2006) cAMP-adenosine pathway in the proximal tubule. J Pharmacol Exp Ther 317:1219-1229.
24. Kelly LA and Butcher RW (1974) The effects of epinephrine and prostaglandin E-1 on cyclic adenosine 3′:5′-monophosphate levels in WI-38 fibroblasts. J Biol Chem 249:3098-3102.
25. Kuster J, Zapf J, and Jakob A (1973) Effects of hormones on cyclic AMP release in perfused rat livers. FEBS Lett 32:73-77.
26. Laube H, Fussganger RD, and Pfeiffer EF (1974) Paradoxical glucagon release in obese hyperglycemic mice. Horm Metab Res 6:426.
27. Moser GH, Schrader J, and Deussen A (1989) Turnover of adenosine in plasma of human and dog blood. Am J Physiol 256:C799-C806.
28. O'Brien JA and Strange RC (1975) The release of adenosine 3′:5′-cyclic monophosphate from the isolated perfused rat heart. Biochem J 152:429-432.
29. Polonsky K, Jaspan J, Emmanouel D, Holmes K, and Moossa AR (1983) Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism. Acta Endocrinol 102:420-427.
30. Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
31. Rosivall L, Mirzahosseini S, Toma I, Sipos A, and Peti-Pterdi J (2006) Fluid flow in the juxtaglomerular interstitium visualized in vivo. Am J Physiol 291:F1241-F1247.
32. Satriano J, Wead L, Cardus A, Deng A, Boss GR, Thomson SC, and Blantz RC (2006) Regulation of ecto-5′-nucleotidase by NaCl and nitric oxide: potential roles in tubuloglomerular feedback and adaptation. Am J Physiol 291:F1078-F1082.
33. Sperling MA (1979) Glucagon: secretion and actions. Adv Exp Med Biol 124:29-61.
34. Taborsky GJ Jr, Ahren B, and Havel PJ (1998) Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes. Diabetes 47:995-1005.
35. Tofovic SP, Branch KR, Oliver RD, Magee WD, and Jackson EK (1991) Caffeine potentiates vasodilator-induced renin release. J Pharmacol Exp Ther 256:850-860.
36. Tofovic SP and Jackson EK (2003) Rat models of the metabolic syndrome, in Methods in Molecular Medicine, Volume 86; Renal Disease: Techniques and Protocols. (Goligorsky MS ed) pp 29-46, Humana Press Inc., Totowa, NJ.
37. Vallon V, Muhlbauer B, and Osswald H (2006) Adenosine and kidney function. Physiol Rev 86:901-940.
38. Vekaria RM, Shirley DG, Sevigny J, and Unwin RJ (2006) Immunolocalization of ectonucleotidases along the rat nephron. Am J Physiol 290:F550-F560.
39. Velliquette RA, Koletsky RJ, and Ernsberger P (2002) Plasma glucagon and free fatty acid responses to a glucose load in the obese spontaneous hypertensive rat (SHROB) model of metabolic syndrome X. Exp Biol Med 227:164-170.
40. Zimmerman H (1992) 5′-Nucleotidase: molecular structure and functional aspects. Biochem J 285:345-365.
41. Zumstein P, Zapf J, and Froesch ER (1974) Effects of hormones on cyclic AMP release from rat adipose tissue in vitro. FEBS Lett 49:65-69.